coronavirns
cv
infect
varieti
livestock
poultri
companion
anim
belong
least
five
antigen
group
cv
caus
local
infect
respiratori
andor
intestin
tract
except
felin
infecti
periton
viru
fipv
hemagglutin
encephalomyel
hev
caus
system
infect
enteropathogen
cv
infect
villou
enterocyt
result
villou
atrophi
lead
malabsorpt
diarrhea
sever
cv
bovin
cvbcv
porcin
respiratori
cvprcv
infecti
bronchiti
virusibv
caus
respiratori
diseas
current
evid
indic
protect
enter
respiratori
cv
infect
mediat
passiv
activ
immun
primari
site
cv
replic
matern
vaccin
approach
induc
passiv
immun
includ
use
inactiv
modifi
live
viral
vaccin
modifi
live
virus
ts
mutant
cv
fipv
also
use
oral
intranas
vaccin
induc
activ
mucos
immun
success
vaccin
field
often
compromis
number
potenti
problem
coronavirus
spheric
envelop
virus
rang
nm
diamet
contain
positivestrand
rna
genom
possess
promin
surfac
spike
speci
display
fring
smaller
surfac
project
believ
hemagglutinin
coronavirus
possess
structur
protein
spike
glycoprotein
kda
integr
membran
glycoprotein
kda
nucleocapsid
phosphoprotein
n
kda
subset
cv
bcv
hev
turkey
cv
possess
third
glycoprotein
virion
surfac
kda
protein
quamit
use
pool
monoclon
antibodi
mab
distinct
epitop
protein
elisa
research
focus
protein
candid
antigen
cv
vaccin
sinc
induc
viru
neutral
vn
antibodi
howev
protein
stimul
product
vn
inhibit
antibodi
protein
induc
antibodi
neutral
viru
presenc
complement
attempt
correl
vitro
vn
antibodi
activ
vivo
protect
shown
passiv
transfer
ofvn
mab
protein
confer
passiv
protect
cv
challeng
studi
other
addit
research
implic
possibl
role
cv
protein
immun
studi
mab
protein
transmiss
gastroenter
tgev
provid
evid
direct
role
protein
induct
aifn
porcin
blood
leukocyt
potenti
signific
phenomenon
immun
tgev
unclear
similarli
studi
ibv
suggest
determin
recogn
cell
resid
n
protein
determin
may
share
among
heterolog
strain
ibv
result
induct
crossprotect
thu
epitop
n
protein
may
import
induct
cell
mediat
immun
cmi
cmi
may
play
import
role
protect
cat
fipv
sinc
induct
circul
antibodi
protein
fipv
contribut
diseas
pathogenesi
induct
immun
complex
antibodi
depend
enhanc
infect
fipv
macrophag
increas
understand
antibodi
cmi
respons
follow
natur
cv
infect
anim
need
identifi
antigen
epitop
induc
protect
immun
respons
express
cv
structur
protein
gene
variou
vector
provid
recombin
protein
need
futur
immunogen
studi
host
speci
furthermor
live
rdna
vector
replic
gut
express
coronaviru
gene
may
provid
new
gener
coronaviru
vaccin
coronavirus
infect
varieti
livestock
poultri
companion
anim
caus
econom
import
diseas
anim
prototyp
coronavirus
host
speci
includ
swine
transmiss
gastroenter
viru
tgev
respiratori
variant
porcin
respiratori
coronaviru
prcv
porcin
epidem
diarrhea
viru
pedv
hemagglutin
encephalomyel
viru
hev
cattl
bovin
coronaviru
bcv
hors
equin
coronaviru
ecv
chicken
infecti
bronchiti
viru
ibv
turkey
turkey
coronaviru
tcv
bluecomb
dog
canin
coronaviru
ccv
cat
felin
infecti
periton
viru
fipv
felin
enter
coronaviru
fecv
saif
heckert
virus
belong
five
distinct
antigen
group
share
within
group
common
antigen
recogn
immunofluoresc
elisa
immunoblot
assay
saif
heckert
wege
et
al
horzinek
et
al
group
includ
group
tgev
prcv
ccv
fipv
fecv
group
bcv
hev
group
ibv
group
tcv
group
pedv
suggest
member
group
may
repres
host
rang
mutant
singl
viru
strain
horzinek
et
al
within
group
viru
pair
tgev
prcv
fipv
fecv
may
repres
variant
one
anoth
alter
tissu
tropism
coronaviru
speci
singl
serotyp
recogn
except
ibv
least
five
serotyp
describ
kuster
et
al
although
fipv
fecv
strain
present
compris
singl
serotyp
strain
vari
greatli
infect
virul
constitut
multipl
biotyp
pedersen
b
scott
mostl
coronavirus
infect
speci
caus
local
infect
respiratori
andor
intestin
tract
except
ibv
strain
also
infect
kidney
oviduct
king
cavenagh
fipv
hev
caus
system
infect
saif
heckert
wege
et
al
mostl
enteropathogen
coronavirus
tgev
pedv
bcv
ecv
tcv
ccv
fecv
infect
villou
enterocyt
result
villou
atrophi
consequ
malabsorpt
diarrhea
saif
heckert
mostl
infect
sever
young
anim
bloodi
diarrhea
associ
coronaviru
shed
fece
report
adult
cattl
winter
dysenteri
saif
pneumoenter
coronaviru
bcv
respiratori
coronavirus
prcv
ibv
induc
respiratori
infect
cattl
swine
chicken
respect
latter
two
coronavirus
replic
nasal
mucosa
trachea
lung
wherea
bcv
replic
respiratori
tissu
distal
small
intestin
colon
saif
heckert
saif
et
al
pensaert
cox
although
respiratori
diseas
commonli
associ
infect
chicken
ibv
strain
king
cavenagh
kuster
et
al
respiratori
infect
associ
bcv
prcv
commonli
mild
subclin
heckert
et
al
pensaert
cox
although
fecv
fipv
strain
initi
replic
epithelium
oropharynx
small
intestin
subsequ
diseas
pathogenesi
differ
stoddart
et
al
pedersen
b
wherea
fecv
strain
like
enter
coronavirus
restrict
replic
matur
villou
epitheli
cell
small
intestin
caus
transient
enter
fipv
strain
cross
mucos
barrier
via
cellassoci
viremia
macrophag
caus
dissemin
diseas
petersen
b
gener
infect
character
inflammatori
exud
bodi
caviti
effus
fip
dissemin
pyogranuloma
noneffus
fip
petersen
b
broad
spectrum
exist
virul
fipv
strain
abil
strain
infect
replic
macrophag
spread
system
correl
virul
stoddart
et
al
serum
antibodi
accentu
pathogenesi
fip
via
gener
immun
complex
deposit
affect
organ
via
mediat
antibodydepend
enhanc
ade
fipv
infect
macrophag
scott
olsen
et
al
current
evid
indic
protect
enter
respiratori
coronaviru
infect
effect
mediat
passiv
activ
mucos
immun
primari
site
viral
replic
saif
jackwood
saif
wesley
presenc
serum
antibodi
usual
fail
correl
protect
enter
coronaviru
infect
hooper
haelterman
heckert
et
al
howev
one
studi
convent
newborn
calv
low
titer
iga
bcv
antibodi
serum
significantli
greater
day
diarrhea
calv
high
titer
serum
iga
antibodi
note
previous
fipv
infect
high
titer
serum
antibodi
actual
exacerb
fip
sensit
cat
subsequ
viral
exposur
pedersen
b
scott
new
approach
vaccin
fipv
base
intranas
administr
live
temperatur
sensit
ts
strain
fipv
replic
primarili
upper
respiratori
tract
gerber
et
al
rational
approach
stimul
local
mucos
immun
siga
cmi
low
level
humor
antibodi
durat
immun
coronaviru
infect
wellstudi
repeat
recrudesc
respiratori
infect
bcv
prcv
ibv
report
calv
sow
chicken
respect
heckert
et
al
callebaut
et
al
jone
ambali
whether
respiratori
immun
coronaviru
infect
shortliv
antigen
variant
coronavirus
frequent
aris
unknown
warrant
studi
young
anim
usual
greatest
risk
develop
sever
diseas
coronaviru
infect
mani
studi
focus
passiv
immun
deriv
mother
prevent
enter
viral
infect
matern
vaccin
approach
induc
protect
level
siga
antibodi
milk
monogastr
antibodi
mammari
secret
cow
provid
effect
passiv
immun
enter
coronavirus
evalu
experiment
challeng
condit
saif
jackwood
saif
wesley
antibodi
provid
lactogen
immun
intestin
wherea
passiv
serum
antibodi
usual
protect
hooper
haelterman
abil
passiv
serum
antibodi
transfer
neonat
via
colostrum
prevent
respiratori
coronaviru
infect
unclear
presenc
low
matern
antibodi
titer
prcv
pig
bcv
calv
prevent
viral
replic
respiratori
tract
heckert
et
al
howev
calf
studi
signific
correl
iga
antibodi
titer
bcv
serum
number
respiratori
sick
day
heckert
et
al
result
similar
observ
studi
bovin
respiratori
syncyti
viru
calv
indic
although
matern
antibodi
prevent
respiratori
diseas
may
moder
sever
kimman
et
al
respiratori
variant
tgev
prcv
recent
emerg
serolog
indistinguish
tgev
possess
alter
pathogen
tropism
respiratori
tissu
pensaert
cox
compar
studi
mucos
immun
attenu
virul
tgev
prcv
pig
provid
ideal
model
explor
concept
common
mucos
immun
system
pig
present
evid
contradictori
whether
sow
previous
infect
prcv
passiv
protect
pig
tgev
bernard
et
al
paton
brown
callebaut
et
al
result
sever
research
indic
pig
previous
infect
prcv
nurs
prcvexpos
dam
partial
protect
upon
challeng
virul
tgev
bernard
et
al
van
nieustadt
et
al
paton
brown
preliminari
data
laboratori
van
cott
et
al
base
enumer
antibodi
secret
cell
asc
mucos
tissu
elispot
indic
virul
tgev
lesser
extent
high
titer
attenu
tgev
stimul
asc
mesenter
lymph
node
mln
infect
pig
asc
detect
mln
prcv
infect
high
number
asc
present
bronchial
lymph
node
pig
find
may
explain
lack
immun
tgev
observ
prcvinfect
pig
van
nieustadt
et
al
recent
report
iga
tgev
antibodi
detect
milk
prcvinfect
sow
tgevinfect
sow
callebaut
et
al
author
note
iga
antibodi
milk
prcvinfect
sow
may
conting
upon
reinfect
prcv
coronavirus
spheric
envelop
virus
rang
nm
diamet
contain
positivestrand
rna
genom
possess
promin
surfac
spike
speci
display
fring
smaller
surfac
project
believ
hemagglutinin
coronavirus
possess
structur
protein
spike
glycoprotein
kda
integr
membran
glycoprotein
kda
nudeocapsid
phosphoprotein
n
kda
subset
coronavirus
bcv
hev
tcv
possess
third
glycoprotein
virion
surfac
kda
wege
et
al
spaan
et
al
saifand
heckert
research
focus
protein
candid
antigen
coronaviru
vaccin
sinc
induc
viru
neutral
vn
antibodi
establish
initi
inocul
anim
purifi
protein
obtain
follow
disrupt
virion
garw
et
al
cavanagh
et
al
recent
ibv
tgev
protein
express
recombin
viral
vector
also
shown
induc
neutral
antibodi
rodent
pulford
et
al
tomley
et
al
godet
et
al
recent
evid
shown
protein
oftgev
ibv
fipv
bcv
induc
neutral
monoclon
antibodi
mab
use
mab
four
major
antigen
site
ad
delin
duster
amino
termin
portion
presum
globular
part
protein
oftgev
delma
et
al
enjuan
et
al
neutralizationmedi
determin
local
ab
domain
conform
depend
highli
conserv
among
tgev
strain
antigenicallyrel
group
coronavirus
prcv
fipv
ccv
delma
et
al
zhu
et
al
mab
site
design
site
b
correa
et
al
crossreact
group
coronavirus
includ
prcv
delma
et
al
simkin
et
al
nonneutr
mab
site
db
use
block
elisa
differenti
sera
pig
infect
tgev
prcv
callebaut
et
al
site
c
compos
linear
epitop
exhibit
antigen
variabl
among
tgev
strain
delma
et
al
unlik
tgev
protein
bcv
ibv
cleav
amino
termin
subunit
carboxi
termin
subunit
laud
spaan
et
al
vautherot
et
al
virus
subunit
major
induc
neutral
mab
ibv
also
major
site
antigen
variat
mockett
et
al
laud
vautherot
et
al
hand
subunit
bcv
may
involv
membran
fusion
infect
reflect
mediat
membran
fusion
insect
cell
infect
recombin
baculoviru
express
bcv
gene
yoo
et
al
protein
ibv
also
exhibit
activ
mockett
et
al
evid
direct
role
protein
induct
protect
immun
coronavirus
contradictori
purifi
protein
ibv
vaccinia
viru
recombin
express
gene
unabl
induc
complet
respiratori
tract
protect
chicken
cavanagh
et
al
spaan
tomley
et
al
kitten
immun
vaccinia
viru
recombin
express
fipv
gene
becam
sensit
fipv
die
challeng
vennena
et
al
attempt
correl
vitro
neutral
antibodi
activ
induc
protein
vivo
protect
also
led
conflict
result
one
studi
administr
ligat
intestin
loop
mixtur
bcv
neutral
mab
domain
bcv
subunit
protein
confer
passiv
protect
calv
bcvinduc
villou
atrophi
howev
neutral
mab
site
undefin
site
protein
tgev
fail
confer
passiv
protect
pig
tgev
challeng
although
polyclon
porcin
antibodi
protect
reason
discrep
uncertain
may
relat
overal
experiment
design
bind
affin
epitop
specif
vivo
stabil
mab
use
viru
challeng
dose
research
need
clarifi
degre
vivo
protect
provid
neutral
mab
protein
coronavirus
recent
report
advers
effect
neutral
mab
protein
fipv
shown
mab
found
mediat
ade
infect
fipv
macrophag
vitro
olsen
et
al
result
correl
ade
fipv
infect
observ
cat
vaccin
recombin
vaccinia
viru
express
protein
fipv
vennema
et
al
protein
stimul
product
viru
neutral
hemagglutinationinhibit
mab
bcv
vautherot
et
al
least
one
studi
neutral
mab
protein
also
confer
passiv
protect
bcv
infect
calv
recent
protein
bcv
clone
express
shown
exhibit
extens
amino
acid
sequenc
homolog
bind
enzymat
properti
similar
influenza
c
viru
parker
et
al
protein
tgev
induc
mab
neutral
viru
presenc
complement
wood
et
al
one
studi
singl
neutral
mab
protein
tgev
test
mab
fail
provid
passiv
protect
pig
challeng
tgev
studi
ofmab
protein
tgev
mab
select
protein
mutant
provid
evid
direct
role
protein
induct
interferon
porcin
blood
leukocyt
charley
laud
laud
et
al
howev
potenti
signific
phenomenon
regard
immun
tgev
unclear
n
protein
bind
virion
rna
provid
structur
basi
helic
nucleocapsid
deduc
amino
acid
sequenc
report
n
protein
ofbcv
tgev
ibv
spaan
et
al
studi
ibv
suggest
determin
recogn
cell
resid
n
protein
boot
et
al
furthermor
determin
share
among
certain
heterolog
strain
ibv
may
explain
crossprotect
induc
certain
heterolog
ibv
strain
protectotyp
immun
mice
apex
nucleocapsid
express
product
induc
cmi
respons
measur
lymphocyt
prolifer
test
cmi
respons
found
immun
pex
protein
express
product
boot
et
al
thu
epitop
n
protein
coronavirus
may
import
induct
cmi
cmi
respons
postul
especi
import
protect
cat
fipv
gerber
et
al
circul
neutral
antibodi
protein
fipv
actual
accentu
pathogenesi
diseas
vennema
et
al
number
modifi
live
kill
coronaviru
vaccin
current
licens
usda
modifi
live
virus
bcv
tgev
ibv
ts
mutant
fipv
usual
administ
oral
intranasauy
induc
activ
mucos
immun
kill
vaccin
administ
parenter
adjuv
avail
induc
activ
passiv
immun
bcv
tgev
ccv
ibv
success
vaccin
field
may
compromis
number
potenti
problem
saif
jackwood
saif
wesley
live
viru
vaccin
effect
induc
activ
immun
must
replic
optim
degre
site
relev
induct
mucos
immun
factor
interfer
effici
replic
presenc
matern
antibodi
may
neutral
vaccin
viru
secondli
attenu
strain
may
fail
replic
extent
requir
induc
protect
immun
site
infect
virul
viru
possibl
complic
live
coronaviru
vaccin
especi
given
highli
suscept
neonat
anim
includ
possibl
revers
virul
presenc
adventiti
agent
vaccin
much
experiment
evid
exist
support
concept
common
mucos
immun
system
enter
infect
induc
immun
respons
protect
respiratori
mucos
surfac
howev
convers
may
true
case
agent
caus
local
respiratori
infect
thu
prcv
strain
replic
almost
exclus
respiratori
tract
fail
induc
complet
protect
tgev
challeng
bernard
et
al
van
nieustadt
et
al
callebaut
et
al
paton
brown
kill
vaccin
usual
administ
parenter
problem
frequent
encount
induc
high
titer
local
siga
antibodi
cmi
respons
often
poor
durat
immun
may
shortliv
hand
kill
vaccin
may
effect
boost
antibodi
titer
anim
recov
natur
infect
coronavirus
saif
jackwood
saif
wesley
kill
vaccin
inactiv
agent
viral
dose
adjuv
import
variabl
evalu
present
potenc
live
coronaviru
vaccin
assess
vitro
titrat
viral
infecti
dose
cell
cultur
titer
correl
minimum
viral
titer
requir
induc
protect
immun
experiment
challeng
also
natur
challeng
field
condit
potenc
kill
vaccin
assess
vaccinationchalleng
test
use
differ
dose
vaccin
certain
titer
neutral
antibodi
induc
inocul
laboratori
anim
vaccin
accept
proven
correl
protect
immun
correl
establish
includ
quantit
particular
viral
antigen
associ
induct
neutral
antibodi
protect
challeng
amount
viral
structur
protein
present
kill
subunit
vaccin
quantit
use
specif
mab
elisa
howev
import
establish
mab
react
relev
epitop
present
intact
viru
use
pool
mab
distinct
viral
epitop
protein
may
increas
assay
sensit
simkin
et
al
scenario
assumpt
made
neutral
antibodi
serum
correl
protect
applic
recombin
r
dna
techniqu
coronavirus
result
cdna
clone
sever
gene
open
new
avenu
vaccin
biotechnolog
studi
focus
glycoprotein
induc
neutral
antibodi
although
review
structur
protein
may
also
play
role
immun
varieti
express
system
develop
product
coronaviru
antigen
coronaviru
protein
glycosyl
eucaryot
express
system
use
obtain
recombin
protein
recent
bcv
protein
parker
et
al
bcv
tgev
glycoprotein
express
baculoviru
recombin
express
system
parker
et
al
godet
et
al
express
tgev
glycoprotein
induc
neutral
antibodi
rat
studi
done
swine
gener
parenter
oral
administr
solubl
protein
induc
poor
mucos
immun
respons
result
toler
induct
andr
et
al
rubin
et
al
therefor
oral
administr
subunit
coronaviru
vaccin
requir
new
mucos
adjuv
deliveri
system
stimul
mucos
immun
second
strategi
use
rdna
technolog
involv
develop
live
vaccin
delet
certain
nonessenti
portion
viral
genom
delet
mutagenesi
use
attenu
viral
pathogen
howev
accomplish
rna
virus
infecti
cdna
clone
requir
yet
avail
coronavirus
subsequ
insert
new
genet
materi
alter
viru
genom
could
provid
marker
identifi
type
vaccin
viru
strain
anoth
approach
involv
use
live
virus
bacteria
vector
express
viral
gene
code
protect
antigen
vector
one
nonessenti
region
capabl
accommod
insert
foreign
gene
present
live
vector
vaccin
coronavirus
limit
recombin
vaccinia
virus
chicken
mice
gnotobiot
pig
immun
vaccinia
viru
recombin
express
gene
ibv
tgev
respect
develop
neutral
antibodi
homolog
viru
cavenagh
et
al
hu
et
al
tomley
et
al
pulford
et
al
howev
immun
chicken
partial
protect
challeng
spaan
two
potenti
vector
may
hold
promis
develop
live
recombin
dna
vaccin
coronavirus
includ
adenovirus
salmonella
attenu
adenoviru
develop
oral
vaccin
human
chanock
et
al
attenu
adenovirus
exist
speci
might
also
develop
live
rdna
vector
permit
express
coronaviru
gene
insert
intestin
similarli
attenu
strain
salmonella
attract
potenti
live
vector
enter
virus
coronavirus
potenti
target
express
protein
directli
lymphoid
tissu
gut
clement
et
al
curtiss
kelli
although
earli
stage
develop
live
rdna
vector
may
play
key
role
gener
futur
coronaviru
vaccin
